Spherical pH-sensitive microparticles have been prepared by reverse phase suspension polymerization technique. Starting polymer has been alpha,beta-poly(N-2-hydroxyethyl)-dl-aspartamide (PHEA) partially derivatized with glycidylmethacrylate (GMA). PHEAGMA copolymer (PHG) has been crosslinked in the presence of acrylic acid (AA) or methacrylic acid (MA) at various concentration. The obtained microparticles have been characterized by FT-IR spectrophotometry, particle size distribution analysis and scanning electron microscopy. In order to have information about water affinity of the prepared samples, swelling measurements have been carried out in aqueous media which simulate some biological fluids. The possibility to employ the prepared samples as pH-sensitive microparticles has been investigated by performing in vitro release studies. Experimental data have showed that the release rate from these microparticles depends on the environmental pH and the chemical structure of the drug.

PITARRESI G, PIERRO P, GIAMMONA G, IEMMA F, MAZZALUPO R, PICCI N (2004). Drug release from α,β-poly(N-2-hydroxyethyl)-DL-aspartamide based microparticles. BIOMATERIALS, 25(18), 4333-4343 [10.1016/J.conrel 2003.11.015].

Drug release from α,β-poly(N-2-hydroxyethyl)-DL-aspartamide based microparticles

PITARRESI, Giovanna;PIERRO, Paola;GIAMMONA, Gaetano;
2004-01-01

Abstract

Spherical pH-sensitive microparticles have been prepared by reverse phase suspension polymerization technique. Starting polymer has been alpha,beta-poly(N-2-hydroxyethyl)-dl-aspartamide (PHEA) partially derivatized with glycidylmethacrylate (GMA). PHEAGMA copolymer (PHG) has been crosslinked in the presence of acrylic acid (AA) or methacrylic acid (MA) at various concentration. The obtained microparticles have been characterized by FT-IR spectrophotometry, particle size distribution analysis and scanning electron microscopy. In order to have information about water affinity of the prepared samples, swelling measurements have been carried out in aqueous media which simulate some biological fluids. The possibility to employ the prepared samples as pH-sensitive microparticles has been investigated by performing in vitro release studies. Experimental data have showed that the release rate from these microparticles depends on the environmental pH and the chemical structure of the drug.
2004
Settore CHIM/09 - Farmaceutico Tecnologico Applicativo
PITARRESI G, PIERRO P, GIAMMONA G, IEMMA F, MAZZALUPO R, PICCI N (2004). Drug release from α,β-poly(N-2-hydroxyethyl)-DL-aspartamide based microparticles. BIOMATERIALS, 25(18), 4333-4343 [10.1016/J.conrel 2003.11.015].
File in questo prodotto:
File Dimensione Formato  
Pitarresietal2004.pdf

Solo gestori archvio

Descrizione: Articolo
Dimensione 418.38 kB
Formato Adobe PDF
418.38 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/6559
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 35
  • ???jsp.display-item.citation.isi??? 35
social impact